Skip to main content

CORRECTION article

Front. Bioeng. Biotechnol., 18 April 2023
Sec. Nanobiotechnology
Volume 11 - 2023 | https://doi.org/10.3389/fbioe.2023.1199818

Corrigendum: 2D-nanomaterials for AKI treatment

Qiaohui Chen,&#x;Qiaohui Chen1,2†Xiaoyuan Wang,&#x;Xiaoyuan Wang2,3†Chao Yuan,&#x;Chao Yuan2,3†Yayun Nan Yayun Nan4*Qiong Huang, Qiong Huang1,5*Kelong Ai, Kelong Ai2,3*
  • 1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • 2Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China
  • 3Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China
  • 4Geriatric Medical Center, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China
  • 5National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China

A Corrigendum on
2D-nanomaterials for AKI treatment

by Chen Q, Wang X, Yuan C, Nan Y, Huang Q and Ai K (2023). Front. Bioeng. Biotechnol. 11:1159989. doi: 10.3389/fbioe.2023.1159989

In the published article, there was an error in the Funding statement. The funding statement for the Key Program of Ningxia Hui Autonomous Region Natural Science Foundation of China was displayed as “No. 2022JJ21059”. The correct Funding statement appears below.

“The Key Program of Ningxia Hui Autonomous Region Natural Science Foundation of China (No. 2022AAC02058).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: two-dimension, nanomaterials, targeted therapy, acute kidney injury, antioxidant therapy

Citation: Chen Q, Wang X, Yuan C, Nan Y, Huang Q and Ai K (2023) Corrigendum: 2D-nanomaterials for AKI treatment. Front. Bioeng. Biotechnol. 11:1199818. doi: 10.3389/fbioe.2023.1199818

Received: 04 April 2023; Accepted: 12 April 2023;
Published: 18 April 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Chen, Wang, Yuan, Nan, Huang and Ai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yayun Nan, bmFueXlfMjAwOUAxNjMuY29t; Qiong Huang, cWlvbmdodWFuZ0Bjc3UuZWR1LmNu; Kelong Ai, YWlrZWxvbmdAY3N1LmVkdS5jbg==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.